| Authors: |
Ruiz E; Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Manz CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Girard A; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Hernández-Guerrero T; Early Phase Clinical Trials Unit, START Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Doger De-Speville B; Early Phase Clinical Trials Unit, START Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Morillo D; Early Phase Clinical Trials Unit, START Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Mahíllo-Fernández I; Biostatistics Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., García-Foncillas J; Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Li E; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Ferrell WJ; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Barnett I; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Moreno V; Early Phase Clinical Trials Unit, START Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Parikh RB; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. |